Source 1primary paper2023MED
Toolkit/CRISPR-based biosensors
CRISPR-based biosensors
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
CRISPR-based biosensors are molecular diagnostic constructs that use CRISPR systems for sequence-specific nucleic acid recognition to detect disease-associated targets. A 2023 review presents them as a strategy for detecting emerging infectious diseases.
Usefulness & Problems
Why this is useful
These biosensors are useful for infectious disease detection because the cited review attributes flexibility, sensitivity, and specificity to CRISPR-based biosensing approaches. The available evidence supports their promise as diagnostic constructs for human health applications.
Source:
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
Problem solved
CRISPR-based biosensors address the need for molecular detection strategies for emerging infectious diseases. The supplied evidence specifically supports their use in detecting infectious disease-associated nucleic acids.
Problem links
Need controllable genome or transcript editing
DerivedCRISPR-based biosensors are molecular diagnostic constructs that use CRISPR systems to detect disease-associated nucleic acids. In the cited 2023 review, they are presented as a strategy for emerging infectious disease detection with reported flexibility, sensitivity, and specificity.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Techniques
No technique tags yet.
Target processes
editingImplementation Constraints
application scope human health: Truecofactor dependency: cofactor requirement unknowndiagnostic focus: infectious disease detectionencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The supplied evidence establishes only that these are CRISPR-based diagnostic constructs for nucleic acid detection. It does not provide practical details on construct architecture, cofactors, delivery, expression systems, readout modalities, or assay conditions.
The provided evidence is limited to a review-level claim and does not specify which CRISPR effector proteins, assay formats, limits of detection, sample types, or validation settings were used. Independent experimental replication and comparative benchmarking are not documented in the supplied material.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
Approval Evidence
1 source3 linked approval claimsfirst-pass slug crispr-based-biosensors
The clustered regularly interspaced short palindromic repeats (CRISPR) technology, as the next-generation molecular diagnosis technique, holds immense promise in the detection of infectious diseases because of its remarkable advantages, including supreme flexibility, sensitivity, and specificity.
Source:
capabilitysupports
CRISPR-based biosensors hold promise for detecting infectious diseases because they offer flexibility, sensitivity, and specificity.
Source:
scopesupports
CRISPR-based biosensing strategies are used to detect disease-associated nucleic acids in the context of infectious disease detection.
Source:
translation needsupports
There remains a critical need to summarize and explore the potential of CRISPR-based biosensors in human health despite their development in environmental monitoring, food safety, and point-of-care diagnosis.
Source:
Comparisons
Source-backed strengths
The cited review states that CRISPR-based biosensors offer flexibility, sensitivity, and specificity for infectious disease detection. This positions them as promising diagnostic tools, although no quantitative performance metrics are provided in the supplied evidence.
CRISPR-based biosensors and CRISPR-Cas genome editors directly modulated by temperature address a similar problem space because they share editing.
Shared frame: same top-level item type; shared target processes: editing
Compared with microhomology templates
CRISPR-based biosensors and microhomology templates address a similar problem space because they share editing.
Shared frame: same top-level item type; shared target processes: editing
Compared with PMNT mixed with single-stranded DNA color reporter
CRISPR-based biosensors and PMNT mixed with single-stranded DNA color reporter address a similar problem space because they share editing.
Shared frame: same top-level item type; shared target processes: editing
Ranked Citations
- 1.